Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesComparison of existing disease activity indices in the follow-up of patients with Behçets disease
Modern Rheumatology, 07/14/09
Shahram F et al. – Study demonstrates that the Iranian Behçet’s disease dynamic activity measure (IBDDAM) was the preferred method for the evaluation of disease activity change in patients with Behçet’s disease (without ocular involvement) considering a change of at least 0.45.
Methods- This study was designed to determine:
- To what degree change in IBDDAM or Behçet’s disease current activity form (BDCAF) values significantly indicates disease activity change, and
- Concordance between IBDDAM or BDCAF and expert physician global assessment (PGA) in the evaluation of disease activity changes in BD
- Prospective study; 117 consecutive pts with BD were evaluated in their 2 consecutive f/u visits by IBDDAM and BDCAF
- Change in disease activity was determined according to PGA
- ROC curve was used to determine an appropriate cutoff point for disease activity change
- Comparison was made by Stata and kappa analysis
- A significant difference between IBDDAM and BDCAF was noted
- The difference was more significant between nonocular IBDDAM and BDCAF
- Better concordance was also observed for IBDDAM with PGA than BDCAF
- Difference was not significant for ocular IBDDAM
- The best cutoff point for nonocular IBDDAM was 0.45, for ocular IBDDAM was 3.5, and for BDCAF was 1 point
Related Articles
Raised concentration of soluble form of vascular endothelial cadherin and IL-23 in sera of patients with Behçets disease
Modern Rheumatology, 11/19/09
Relevance Score: 87%
The impact of comorbidity on physical function in patients with rheumatoid arthritis
Annals of Rheumatic Diseases, 10/26/09
Relevance Score: 84%
Analysis of correlations between selected endothelial cell activation markers, disease activity, and nailfold capillaroscopy microvascular changes in SLE patients
Clinical Rheumatology, 11/17/09
Relevance Score: 83%
The Antiapoptotic Activity of Melatonin in Neurodegenerative Diseases
CNS Neuroscience & Therapeutics, 11/11/09
Relevance Score: 83%
Celiac disease, Behçet, and idiopathic thrombocytopenic purpura in siblings of a patient with multiple sclerosis
Multiple Sclerosis, 10/26/09
Relevance Score: 83%
Today in Vasculitic Syndromes...keeping you current
Receive free subspecialty "5-minute updates" via email
Is there any relationship between serum and urine neopterin and serum interferon-gamma levels in the activity of Behcet's disease?
Journal of the European Academy of Dermatology and Venereology, 12/04/09
Study on association between polymorphism of HLA-DRB1 alleles and Behcet's disease
Journal of the European Academy of Dermatology and Venereology, 12/04/09
Rituximab may form a complex with iGm[kappa] mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis
Arthritis & Rheumatism, 12/03/09
Sponsor
Article Search
Sponsor